{"cik":1990550,"taxonomy":"us-gaap","tag":"AllocatedShareBasedCompensationExpense","label":"Share-based Payment Arrangement, Expense","description":"Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.","entityName":"Ambrx Biopharma, Inc.","units":{"USD":[{"start":"2022-01-01","end":"2022-09-30","val":5067000,"accn":"0000950170-23-062916","fy":2023,"fp":"Q3","form":"10-Q","filed":"2023-11-13"},{"start":"2022-07-01","end":"2022-09-30","val":1538000,"accn":"0000950170-23-062916","fy":2023,"fp":"Q3","form":"10-Q","filed":"2023-11-13","frame":"CY2022Q3"},{"start":"2023-01-01","end":"2023-09-30","val":9644000,"accn":"0000950170-23-062916","fy":2023,"fp":"Q3","form":"10-Q","filed":"2023-11-13"},{"start":"2023-07-01","end":"2023-09-30","val":4820000,"accn":"0000950170-23-062916","fy":2023,"fp":"Q3","form":"10-Q","filed":"2023-11-13","frame":"CY2023Q3"}]}}